An Act amending Title 35 (Health and Safety) of the Pennsylvania Consolidated Statutes, providing for telemedicine prohibited for medication safety.

This bill amends Pennsylvania law to prohibit healthcare providers from using telemedicine to prescribe certain medications to patients within the state. Specifically, it disallows the use of telemedicine for medications that the U.S. Food and Drug Administration (FDA) has designated with a "risk evaluation and mitigation strategy." These strategies are special safety programs implemented by the FDA for medications with specific serious risks. The aim is to enhance medication safety by ensuring such medications are not prescribed remotely via telemedicine.